Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Watching Revance Therapeutics; Shares Trading Lower Amid Crown Laboratories Failing To Start A Tender Offer For The Co By The Friday September 13, 2024 Deadline; Crown Labs Agreed To Acquire The Co Last Month For $6.66/Share In Cash, Had Already Extended The Offer From An Original August 30, 2024 Deadline

Author: Benzinga Newsdesk | September 16, 2024 03:54pm

Posted In: RVNC